Related Experiment Videos
[Molecular defects in familial LCAT deficiency]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1993
Summary
Familial LCAT deficiency and fish eye disease result from mutations in the Lecithin: cholesterol acyltransferase (LCAT) gene. Genetic defects in LCAT cause lipid metabolism disorders with distinct clinical features.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Lecithin: cholesterol acyltransferase (LCAT) is crucial for cholesterol esterification in lipoproteins.
- Familial LCAT deficiency is a rare, autosomal recessive disorder affecting lipid metabolism.
- Clinical manifestations include corneal opacity, anemia, and potential renal failure.
Purpose of the Study:
- To investigate the genetic basis of familial LCAT deficiency and fish eye disease.
- To identify mutations in the LCAT gene responsible for these conditions.
Main Methods:
- DNA analysis of patients with familial LCAT deficiency and fish eye disease.
- Gene sequencing of the LCAT gene.
Main Results:
- Mutations in the LCAT gene were identified in patients with familial LCAT deficiency.
- Distinct LCAT gene mutations were found in patients with fish eye disease.
- These genetic defects correlate with observed clinical and biochemical abnormalities.
Conclusions:
- Genetic defects in the LCAT gene are the underlying cause of familial LCAT deficiency and fish eye disease.
- LCAT gene mutations lead to functional abnormalities affecting lipid metabolism and clinical presentation.